This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emery, S.
Right arrow Articles by Overbaugh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emery, S.
Right arrow Articles by Overbaugh, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2000, p. 2688-2695, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Evaluation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay Using Primary Subtype A, C, and D Isolates from Kenya

Sandra Emery,1,2 Sharon Bodrug,3 Barbra A. Richardson,4 Cristina Giachetti,3 Martha A. Bott,3 Dana Panteleeff,1 Linda L. Jagodzinski,5 Nelson L. Michael,6 Ruth Nduati,7 Job Bwayo,8 Joan K. Kreiss,2,9 and Julie Overbaugh1,*

Division of Human Biology, Fred Hutchinson Cancer Research Center,1 and Departments of Biostatistics,4 Medicine,2 and Epidemiology,9 University of Washington, Seattle, Washington; Gen-Probe Incorporated, San Diego, California3; Henry M. Jackson Foundation,5 and Division of Retrovirology, Walter Reed Army Institute of Research,6 Rockville, Maryland; and Departments of Pediatrics7 and Medical Microbiology,8 University of Nairobi, Nairobi, Kenya

Received 11 November 1999/Returned for modification 13 March 2000/Accepted 24 April 2000

Accurate and sensitive quantification of human immunodeficiency virus type 1 (HIV-1) RNA has been invaluable as a marker for disease prognosis and for clinical monitoring of HIV-1 disease. The first generation of commercially available HIV-1 RNA tests were optimized to detect the predominant HIV-1 subtype found in North America and Europe, subtype B. However, these tests are frequently suboptimal in detecting HIV-1 genetic forms or subtypes found in other parts of the world. The goal of the present study was to evaluate the performance of a new viral load assay with non-subtype B viruses. A transcription-mediated amplification method for detection and quantitation of diverse HIV-1 subtypes, called the Gen-Probe HIV-1 viral load assay, is under development. In this study we examined the performance of the Gen-Probe HIV-1 viral load assay relative to that of the commonly used commercial HIV-1 RNA assays using a panel of primary isolates from Kenya. For comparison, we included several subtype B cloned viruses, and we quantified each virus using an in-house quantitative-competitive reverse transcriptase PCR (QC-RT-PCR) method and gagp24 antigen capture. The Gen-Probe HIV-1 viral load assay and a version of the Roche AMPLICOR HIV-1 MONITOR test (version 1.5) that was designed to detect a broader range of subtypes were both sensitive for the quantification of Kenyan primary isolates, which represented subtype A, C, and D viruses. The Gen-Probe HIV-1 viral load assay was more sensitive for the majority of viruses than the Roche AMPLICOR HIV-1 MONITOR test version 1.0, the Bayer Quantiplex HIV RNA 3.0 assay, or a QC-RT-PCR method in use in our laboratory, suggesting that it provides a useful method for quantifying HIV-1 RNAs from diverse parts of the world, including Africa.


* Corresponding author. Mailing address: Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., C3-168, Seattle, WA 98109. Phone: (206) 667-3524. Fax: (206) 667-1535. E-mail: joverbau{at}fhcrc.org.


Journal of Clinical Microbiology, July 2000, p. 2688-2695, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Voronin, Y., Chohan, B., Emerman, M., Overbaugh, J. (2007). Primary Isolates of Human Immunodeficiency Virus Type 1 Are Usually Dominated by the Major Variants Found in Blood. J. Virol. 81: 10232-10241 [Abstract] [Full Text]  
  • Benki, S., McClelland, R. S., Emery, S., Baeten, J. M., Richardson, B. A., Lavreys, L., Mandaliya, K., Overbaugh, J. (2006). Quantification of Genital Human Immunodeficiency Virus Type 1 (HIV-1) DNA in Specimens from Women with Low Plasma HIV-1 RNA Levels Typical of HIV-1 Nontransmitters. J. Clin. Microbiol. 44: 4357-4362 [Abstract] [Full Text]  
  • Sagar, M., Lavreys, L., Baeten, J. M., Richardson, B. A., Mandaliya, K., Chohan, B. H., Kreiss, J. K., Overbaugh, J. (2003). Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression. J. Virol. 77: 12921-12926 [Abstract] [Full Text]  
  • Mbori-Ngacha, D., Richardson, B. A., Overbaugh, J., Panteleeff, D. D., Nduati, R., Steele, M., John-Stewart, G. (2003). Short-Term Effect of Zidovudine on Plasma and Genital Human Immunodeficiency Virus Type 1 and Viral Turnover in These Compartments. J. Virol. 77: 7702-7705 [Abstract] [Full Text]  
  • Richardson, B. A., Mbori-Ngacha, D., Lavreys, L., John-Stewart, G. C., Nduati, R., Panteleeff, D. D., Emery, S., Kreiss, J. K., Overbaugh, J. (2003). Comparison of Human Immunodeficiency Virus Type 1 Viral Loads in Kenyan Women, Men, and Infants during Primary and Early Infection. J. Virol. 77: 7120-7123 [Abstract] [Full Text]  
  • DeVange Panteleeff, D., Emery, S., Richardson, B. A., Rousseau, C., Benki, S., Bodrug, S., Kreiss, J. K., Overbaugh, J. (2002). Validation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay with Genital Swabs and Breast Milk Samples. J. Clin. Microbiol. 40: 3929-3937 [Abstract] [Full Text]